A business in context
BMY research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-15 | Haller Julia A | M · Exercise / conversion | Common Stock, $0.10 par value | 20460.0 | 53.76 |
| 2026-06-15 | Haller Julia A | M · Exercise / conversion | Option (right to buy) | 20460.0 | 0.0 |
| 2026-06-03 | Short Bartie Wendy | F · Tax / exercise payment | Common Stock, $0.10 par value | 3876.0 | 54.72 |
| 2026-06-03 | Short Bartie Wendy | M · Exercise / conversion | Common Stock, $0.10 par value | 8040.0 | 0.0 |
| 2026-06-03 | Short Bartie Wendy | M · Exercise / conversion | Restricted Stock Units | 8040.0 | 0.0 |
| 2026-05-01 | Lenkowsky Adam | J · Other (see filing) | Common Stock, $0.10 par value | 203.0 | 0.0 |
| 2026-05-01 | Lenkowsky Adam | M · Exercise / conversion | Common Stock, $0.10 par value | 1373.0 | 0.0 |
| 2026-05-01 | Lenkowsky Adam | F · Tax / exercise payment | Common Stock, $0.10 par value | 599.0 | 58.22 |
| 2026-05-01 | Lenkowsky Adam | M · Exercise / conversion | Market Share Units | 1373.0 | 0.0 |
| 2026-04-01 | Shanahan Karin | M · Exercise / conversion | Common Stock, $0.10 par value | 3307.0 | 0.0 |
| 2026-04-01 | Shanahan Karin | F · Tax / exercise payment | Common Stock, $0.10 par value | 1692.0 | 61.73 |
| 2026-04-01 | Shanahan Karin | M · Exercise / conversion | Restricted Stock Units | 3307.0 | 0.0 |
| 2026-04-01 | Elkins David V | S · Sale | Common Stock, $0.10 par value | 25519.0 | 61.6 |
| 2026-04-01 | Elkins David V | S · Sale | Common Stock, $0.10 par value | 4481.0 | 62.05 |
| 2026-03-31 | Samuels Theodore R. II | A · Grant / award | Deferred Share Units | 845.01 | 60.65 |
| 2026-03-31 | McMullen Michael R. | A · Grant / award | Deferred Share Units | 577.08 | 60.65 |
| 2026-03-31 | Rice Derica W | A · Grant / award | Deferred Share Units | 638.91 | 60.65 |
| 2026-03-31 | Arduini Peter J | A · Grant / award | Deferred Share Units | 577.08 | 60.65 |
| 2026-03-31 | YALE PHYLLIS R | A · Grant / award | Deferred Share Units | 577.08 | 60.65 |
Identity & relationships
SEC issuer · 0000014272BRISTOL MYERS SQUIBB CO
Bristol-Myers Squibb (Japan)Bristol Myers Squibb (Canada)Bristol-Myers Squibb (India)Kosan BiosciencesBristol-Myers Squibb (Germany)
Search names and former names
View Wikidata identity and references ↗
- Bristol-Myers Squibb · alias · wikidata
- BMS · alias · wikidata
- Bristol Myers Squibb · alias · wikidata
- Bristol-Myers Squibb (Japan) · subsidiary · wikidata
- Bristol Myers Squibb (Canada) · subsidiary · wikidata
- Bristol-Myers Squibb (India) · subsidiary · wikidata
- Kosan Biosciences · subsidiary · wikidata
- Bristol-Myers Squibb (Germany) · subsidiary · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $48.30B | $51.41B |
| 2023-12-31 | $45.01B | $49.32B |
| 2022-12-31 | $46.16B | $52.66B |
| 2021-12-31 | $46.38B | $57.15B |
| 2020-12-31 | $42.52B | $54.86B |
| 2019-12-31 | $26.14B | $34.15B |
| 2018-12-31 | $22.56B | $30.00B |
| 2017-12-31 | $20.78B | $28.30B |